Aliases & Classifications for Alexia

About this section

Aliases & Descriptions for Alexia:

Name: Alexia 10 12 65
Dyslexia 36 65
Dyslexia, Acquired 65
 
Acquired Dyslexia 10
Aphemesthaesia 10

Classifications:



External Ids:

Disease Ontology10 DOID:13417
ICD9CM29 315.01
UMLS65 C0002018, C0013388

Summaries for Alexia

About this section
Disease Ontology:10 An agnosia that is a loss of the ability to recognize text.

MalaCards based summary: Alexia, also known as dyslexia, is related to headache and cerebritis. An important gene associated with Alexia is PSEN1 (Presenilin 1), and among its related pathways are A-beta Signaling Pathways and Alzheimers Disease Pathway. Affiliated tissues include brain, thyroid and heart, and related mouse phenotypes are muscle and nervous system.

Related Diseases for Alexia

About this section

Graphical network of the top 20 diseases related to Alexia:



Diseases related to alexia

Symptoms for Alexia

About this section

Drugs & Therapeutics for Alexia

About this section

Drugs for Alexia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 31)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Rivastigmineapproved, investigationalPhase 481123441-03-277991
Synonyms:
(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate
123441-03-2
3-((1S)-1-(Dimethylamino)ethyl)phenyl N-ethyl-N-methylcarbamate
3-((1S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate
3-[(1S)-1-(dimethylamino)ethyl]phenyl ethyl(methyl)carbamate
AB1004572
AC1L2U92
BIDD:GT0316
C11766
CHEMBL636
CID77991
Carbamic acid, N-ethyl-N-methyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester
Carbamic acid, ethylmethyl-, 3-((1S)-1-(dimethylamino)ethyl)phenyl ester
D03822
DB00989
ENA 713 free base
Ena 713 Free Base
 
Ethylmethylcarbamic acid 3-((1S)-1-(dimethylamino)ethyl)phenyl ester
Exelon
Exelon Patch
HMS2089H18
I06-2037
LS-172571
MolPort-003-666-662
NCGC00167531-01
Rivastigmine
Rivastigmine (JAN/USAN/INN)
Rivastigmine Hydrogen Tartrate
Rivastigmine [USAN:INN]
Rivastigmine hydrogen tartrate
SDZ 212-713
UNII-PKI06M3IW0
[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate
m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate
rivastigmine
2Protective AgentsPhase 45651
3Neurotransmitter AgentsPhase 414795
4Neuroprotective AgentsPhase 41376
5Cholinesterase InhibitorsPhase 4498
6Cholinergic AgentsPhase 43243
7Imatinib MesylatePhase 4577123596
8
TolvaptanapprovedPhase 384150683-30-0216237, 443894
Synonyms:
( -)-4'-((7-Chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl)carbonyl)-o-tolu-m-toluidide
150683-30-0
7-Chloro-5-hydroxy-1-(2-methyl-4-(2-methylbenzoylamino)benzoyl)2,3,4,5-tetrahydro-1H-1-benzazepine
AC1L50C9
C116664
CHEBI:327437
CHEMBL344159
CID216237
 
L001628
N-[4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methylphenyl]-2-methylbenzamide
OPC 41061
OPC-41061
PDSP1_001738
PDSP2_001721
Samsca
Tolvaptan
UNII-21G72T1950
benzazepine derivative, 32
9
ZincapprovedPhase 314777440-66-623994, 32051
Synonyms:
30Zn
Cinc
Zinc
Zinc ion
 
Zincum
Zink
Zn
Zn(ii)
Zn2+
10
PancrelipaseapprovedPhase 388053608-75-6
Synonyms:
1,4-alpha-D- glucan glucanohydrolase
Creon
PA
Pancreatic alpha-amylase precursor
Pancreaze
 
Pancrelipase
Pertzye
Polocaine-mpf
Ultresa
Viokace
Zenpep
11
Insulin DetemirapprovedPhase 3189169148-63-45311023
Synonyms:
Insulin detemir
Insulin detemir recombinant
Levemir
 
Levemir flexpen
Levemir innolet
Levemir penfill
NN-304
12pancreatinPhase 3880
13Insulin, Long-ActingPhase 3123
14Insulin, Globin ZincPhase 34278
15HormonesPhase 311748
16insulinPhase 34278
17Natriuretic AgentsPhase 31403
18Arginine VasopressinPhase 3264
19Hypoglycemic AgentsPhase 34503
20VasopressinsPhase 3260
21
IfosfamideapprovedPhase 1, Phase 23713778-73-23690
Synonyms:
(+-)-Ifosfamid
(+-)-Ifosphamide
(+-)-Tetrahydro-N,3-bis(2-chloroethyl)-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
(D,L)-Ifosfamide
(R,S)-Ifosphamide
(R,S)-N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide
1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide
2,3-(N,N(sup 1)-Bis(2-chloroethyl)diamido)-1,3,2-oxazaphosphoridinoxyd
2,3-N,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxyd
2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis( 2-chloroethyl)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide (8CI)
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide
3,} 2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-((2-chloroethyl)amino)perhydro-2H-1,3,2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorineoxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2- oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide
36341-88-5
3778-73-2
84711-20-6
A 4942
AB00513932
AC-2113
AC1L1GHW
ASTA Z 4942
Ambap3778-73-2
Asta Z 4942
BPBio1_000865
BRN 0611835
BSPBio_000785
C07047
CAS-3778-73-2
CCRIS 352
CHEBI:5864
CHEMBL1024
CID3690
Cyfos
D00343
D007069
DB01181
EINECS 223-237-3
HMS1570H07
HMS2090M12
HMS2093N07
HSDB 7023
Holoxan
Holoxan 1000
I-Phosphamide
I06-0494
IFEX (TN)
Ifex
Ifosfamid
Ifosfamida
Ifosfamida [INN-Spanish]
Ifosfamide
 
Ifosfamide (JAN/USP/INN)
Ifosfamide Sterile
Ifosfamide [USAN:INN:BAN:JAN]
Ifosfamidum
Ifosfamidum [INN-Latin]
Ifosphamide
Ifsofamide
Iphosphamid
Iphosphamid(e)
Iphosphamide
Iso Endoxan
Iso-Endoxan
Isoendoxan
Isofosfamide
Isophosphamide
Isosfamide
LS-102
LS-99799
MJF 9325
MJF-9325
MLS002154021
Mitoxana
Mitoxana, Ifex, Ifosfamide
MolPort-003-666-704
N,3-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
N,N-Bis(beta-chloroethyl)-amino-N',O-propylene-phosphoric acid ester diamide
N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid
N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid [German]
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylen ephosphoric acid diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylene phosphoric acid ester diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid ester diamide
N-(2-Chloroethyl)-N-(3-(2-chloroethyl)-2-oxido-1,3,2-oxazaphosphinan-2-yl)amine
NCGC00016639-01
NCGC00179435-01
NCI-C01638
NCI60_000233
NPFAPI-04
NSC 109,724
NSC 109724
NSC-109,724
NSC-109724
NSC109,724
NSC109724
Naxamide
Prestwick0_000833
Prestwick1_000833
Prestwick2_000833
Prestwick3_000833
S1302_Selleck
SMR001233348
SPBio_002706
STL058690
UNII-UM20QQM95Y
WLN: T6NPOTJ AM2G BO B2G
Z 4942
Z-4942
Z4942
ifosfamide
isosfamide
{3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,
22
EtoposideapprovedPhase 1, Phase 2116933419-42-036462
Synonyms:
(-)-Etoposide
121471-01-0
136598-18-0
201594-04-9
33419-42-0
35317-32-9
4'-Demethyl-epipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside
4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside)
4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside)
4'-Demethylepipodophyllotoxin ethylidene-.beta.-D-glucoside
4'-O-Demethyl-1-O-(4,6-O-ethylidene-beta-D-glucopyranosyl)epipodophyllotoxin
4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside
4-Demethylepipodophyllotoxin-.beta.-D-ethylideneglucoside
51854-34-3
76576-58-4
9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one
AB00438905
AC1L1FN8
AC1L1VT3
AC1L6246
AC1NR4OG
AC1O4WGG
AC1O7M1N
AC1Q47JJ
Ambap33419-42-0
BPBio1_000673
BRD-K37798499-001-02-5
BSPBio_000611
Bio1_000489
Bio1_000978
Bio1_001467
C01576
CCRIS 2392
CHEBI:4911
CHEBI:588795
CHEMBL44657
CID11758093
CID284997
CID3310
CID36462
CID5284558
CID6419930
CID6610299
CPD000112002
D00125
DB00773
DEMETHY-EPIPODOPHYLLOTOXIN,ETHYLIDENE GLUCOSIDE,
Demethyl Epipodophyllotoxin Ethylidine Glucoside
Demethyl-epiodophyllotoxin ethylidene glucoside
Demethylepipodophyllotoxin-beta-D-ethylideneglucoside
E0675
E1383_SIGMA
EINECS 251-509-1
EPE
EPEG
ETOP
Epipodophyllotoxin
Epipodophyllotoxin VP-16213
Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-.beta.-D-glucopyranoside
Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside
Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside (8CI)
Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-.beta.-D-glucopyranoside)
Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-beta-D-glucopyranoside)
Eposide
Eposin
Eposin, Vepesid, VP-16, Toposar, Etoposide
 
Etopol
Etopophos
Etopophos (phosphate salt)
Etoposid
Etoposide
Etoposide (JP15/USP/INN)
Etoposide (VP16)
Etoposide Phosphate
Etoposide [USAN:INN:BAN:JAN]
Etoposido
Etoposido [INN-Spanish]
Etoposidum
Etoposidum [INN-Latin]
Etosid
HMS1569O13
HMS2052N05
HMS2089F14
HSDB 6517
I06-0248
KBioSS_002410
LS-1214
Lastet
MLS000049957
MLS001074951
MLS001424283
MLS002153463
MLS002207239
MLS002222184
MolPort-003-983-431
MolPort-004-905-001
MolPort-004-955-161
NCGC00025056-02
NChemBio.2007.10-comp19
NK 171
NSC 141540
NSC-141540
NSC141540
Prestwick0_000396
Prestwick1_000396
Prestwick2_000396
Prestwick3_000396
Prestwick_211
S1225_Selleck
SAM001246880
SMR000112002
SPBio_002532
ST056353
Toposar
UNII-6PLQ3CP4P3
VP 16
VP 16 (pharmaceutical)
VP 16-213
VP 16213
VP-16
VP-16-213
VePESID (TN)
VePesid
Vepesid
Vepesid J
Vepeside
ZINC03830818
ZINC03938684
Zuyeyidal
etoposide
nchembio.573-comp8
nchembio873-comp2
trans-Etoposide
23ImmunoglobulinsPhase 1, Phase 24477
24Isophosphamide mustardPhase 1, Phase 2371
25Calcium, DietaryPhase 24678
26Immunologic FactorsPhase 1, Phase 218483
27Antibodies, MonoclonalPhase 1, Phase 22413
28Alkylating AgentsPhase 1, Phase 23582
29AntibodiesPhase 1, Phase 24477
30Antineoplastic Agents, AlkylatingPhase 1, Phase 23406
31Etoposide phosphatePhase 1, Phase 21169

Interventional clinical trials:

(show all 14)
idNameStatusNCT IDPhase
1Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44CompletedNCT00948766Phase 4
2Pre-operative Biliary SEMS RCT During Neoadjuvant TherapyRecruitingNCT02238847Phase 4
3Chemotherapy and Imatinib in Young Adults With Acute Lymphoblastic Leukemia Ph (BCR-ABL) POSITIVERecruitingNCT01491763Phase 4
4Study of the Safety and Effectiveness of SAMSCA® (Tolvaptan) in Children and Adolescents With Euvolemic or Hypervolemic HyponatremiaRecruitingNCT02012959Phase 3
5Cystic Fibrosis - Insulin Deficiency, Early ActionRecruitingNCT01100892Phase 3
6Multimodal Treatment of Phonological Alexia: Behavioral & fMRI OutcomesCompletedNCT00827268Phase 1, Phase 2
7Brentuximab Vedotin in Refractory/Relapsed Hodgkin Lymphoma Treated by ICERecruitingNCT02686346Phase 1, Phase 2
8Treatments of the Post-traumatic Necrosed Immature Teeth (REV)RecruitingNCT02064517Phase 2
9Therapy for Reading Problems in Adults After Brain InjuryCompletedNCT00064805
10Initiating and Maintaining Physical Activity in Depressed IndividualsRecruitingNCT02691845
11Preoperative Treatment With Noninvasive Intra-auricular Vagus Nerve Stimulation Pending Bariatric SurgeryRecruitingNCT02648191
12Brain Mechanisms Underlying Reading Improvement in Central AlexiaActive, not recruitingNCT02062619
13Effects of Music Education for Children With Reading DifficultiesActive, not recruitingNCT01388881
14App-delivered Therapy for Arabic Readers With Hemianopic AlexiaNot yet recruitingNCT02482350

Search NIH Clinical Center for Alexia


Cochrane evidence based reviews: dyslexia

Genetic Tests for Alexia

About this section

Anatomical Context for Alexia

About this section

MalaCards organs/tissues related to Alexia:

33
Brain, Thyroid, Heart, Skin, Lung, Bone, T cells

Animal Models for Alexia or affiliated genes

About this section

MGI Mouse Phenotypes related to Alexia:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053698.2APOE, PPP3CA, PSEN1, TARDBP
2MP:00036317.8APOE, MBP, PPP3CA, PSEN1, TARDBP
3MP:00053767.6APOE, MBP, PPP3CA, PSEN1, TARDBP
4MP:00107687.5APOE, MBP, PPP3CA, PSEN1, TARDBP
5MP:00053977.5APOE, MBP, PPP3CA, PSEN1, TARDBP
6MP:00053877.2APOE, MBP, PPP3CA, PSEN1, TARDBP

Publications for Alexia

About this section

Articles related to Alexia:

(show top 50)    (show all 306)
idTitleAuthorsYear
1
Lactobacillus acidophilus Mixture in Treatment of Children Hospitalized With Acute Diarrhea. (26581358)
2015
2
Filariasis serosurvey, New Caledonia, South Pacific, 2013. (25889011)
2015
3
Pain-related Somato Sensory Evoked Potentials: a potential new tool to improve the prognostic prediction of coma after cardiac arrest. (26573633)
2015
4
Unmethylated CpG motifs in the L. donovani DNA regulate TLR9-dependent delay of programmed cell death in macrophages. (25473100)
2015
5
Thrombophilia in patients with chronic immune thrombocytopenia. (25296772)
2014
6
Stress-induced phosphorylation of Thr486 in c-Myb by p38 mitogen-activated protein kinases attenuates conjugation of SUMO-2/3. (24257756)
2013
7
Protective role of vitamin D signaling in skin cancer formation. (23059470)
2013
8
Epidermal growth factor receptor localized to exosome membranes as a possible biomarker for lung cancer diagnosis. (24400444)
2013
9
The Autonomic Nervous System Questionnaire and the Brief Patient Health Questionnaire as screening instruments for panic disorder in Finnish primary care. (23273422)
2013
10
Merkel cell polyomavirus is frequently detected in korean patients with merkel cell carcinoma. (23717012)
2013
11
Niemann-Pick disease type A presenting as unilateral tremors. (23255701)
2012
12
Comparison of denture microwave disinfection and conventional antifungal therapy in the treatment of denture stomatitis: a randomized clinical study. (22986242)
2012
13
Bronchoscopic intervention obviates the need for continued mechanical ventilation in patients with airway obstruction and respiratory failure from inoperable non-small-cell lung cancer. (22759948)
2012
14
Extraskeletal myxoid chondrosarcoma: a review of 23 patients treated at a single referral center with long-term follow-up. (22678528)
2012
15
Education and Imaging: Gastrointestinal: gastroduodenal involvement of ALK-positive anaplastic large cell lymphoma. (21488949)
2011
16
Absence of neuropsychological impairment in hyperammonaemia in healthy young adults; possible synergism in development of hepatic encephalopathy (HE) symptoms? (21773808)
2011
17
The presence of autoimmune thyroiditis in mixed cryoglobulinemia patients is associated with high levels of circulating interleukin-6, but not of tumor necrosis factor-alpha. (21385538)
2011
18
Combined detection of p53, p16, Rb, and EGFR mutations in lung cancer by suspension microarray. (20082263)
2009
19
Morphine dependence increases the response to a brief pentylenetetrazol administration in rat hippocampal CA1 in vitro. (19183220)
2009
20
Enthesopathy of the bicipital tuberosity of the radius causing painful forearm rotation. (19046644)
2009
21
Functional assessment of allelic variants in the SLC26A4 gene involved in Pendred syndrome and nonsyndromic EVA. (19017801)
2008
22
Myxofibrosarcoma in the skin. (18494817)
2008
23
Mutational analysis of the human MBX gene in four Korean families demonstrating microphthalmia with congenital cataract. (17990594)
2007
24
Erythropoiesis-stimulating agent hyporesponsiveness. (17635745)
2007
25
Nephrocalcinosis in phosphate nephropathy following oral phosphate purgative: a role for underlying subclinical primary hyperparathyroidism? (18037110)
2007
26
The dual function of plant peroxiredoxins in antioxidant defence and redox signaling. (18084899)
2007
27
Incidental finding of lung cancer in a patient with thoracic aortic aneurysm - simultaneous management. A case report. (17587365)
2007
28
Bronchoalveolar cellularity and interleukin-8 levels in measles bronchiolitis obliterans. (17494793)
2007
29
The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease. (15835262)
2005
30
Proteolytic processing of myostatin is auto-regulated during myogenesis. (15975431)
2005
31
Familial hypercholesterolaemia. (18516203)
2004
32
Pellagra encephalopathy following B-complex vitamin treatment without niacin. (15242145)
2004
33
A novel nonsense mutation with a compound heterozygous mutation in TGFBI gene in lattice corneal dystrophy type I. (12586172)
2003
34
Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans. (14643063)
2003
35
Characterization of chicken CENP-A and comparative sequence analysis of vertebrate centromere-specific histone H3-like proteins. (14563550)
2003
36
Association of human TFIID-promoter complexes with silenced mitotic chromatin in vivo. (11744923)
2002
37
Effect of wortmannin on endocytosis of epidermal growth factor receptors]. (11347471)
2001
38
Different point mutations in the met oncogene elicit distinct biological properties. (10657996)
2000
39
A cholesterol-lowering gene maps to chromosome 13q. (10631147)
2000
40
Is amyloid beta-protein glycated in Alzheimer's disease? (9141062)
1997
41
Clustering of Caucasian Leber hereditary optic neuropathy patients containing the 11778 or 14484 mutations on an mtDNA lineage. (9012411)
1997
42
Serum conjugated bile acid profile during intrahepatic cholestasis of pregnancy. (7751589)
1995
43
Protein-bound 3,4-dihydroxyphenylalanine is a major reductant formed during hydroxyl radical damage to proteins. (8387814)
1993
44
Amino acid sequence of the region of beta 2-glycoprotein 1 (gp1) which mediates binding of autoantibodies to the cardiolipin-gp1 complex in humans. (8244459)
1993
45
Long-term follow up of serum thyroglobin levels and its clinical implications in subjects after surgical removal of "cold" thyroid nodule. (1526262)
1992
46
Characterization of inhibitory activities secreted by THP-1 leukemia cells and regulation by interferon-gamma. (1842567)
1991
47
The cdc25 protein controls tyrosine dephosphorylation of the cdc2 protein in a cell-free system. (1825803)
1991
48
A review of the recent literature on diseases of the vulva. II. Vulvitis: infections. (4339629)
1972
49
Prophylaxis against postinfusion phlebitis. (5565353)
1971
50
BRONCHOPNEUMONIA WITH SECONDARY HAEMORRHAGIC MENINGITIS AND RECOVERY. (20768003)
1916

Variations for Alexia

About this section

Expression for genes affiliated with Alexia

About this section
Search GEO for disease gene expression data for Alexia.

Pathways for genes affiliated with Alexia

About this section

Pathways related to Alexia according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.5PPP3CA, PSEN1
29.5APOE, PSEN1
39.3MBP, PPP3CA
4
Show member pathways
9.0APOE, PPP3CA, PSEN1

GO Terms for genes affiliated with Alexia

About this section

Cellular components related to Alexia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1endoplasmic reticulumGO:00057839.5APOE, PSEN1

Biological processes related to Alexia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1response to oxidative stressGO:00069799.2APOE, PSEN1
2negative regulation of protein phosphorylationGO:00019339.2PSEN1, TARDBP

Sources for Alexia

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet